These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 36107386

  • 1. A Computational Study of Carbazole Alkaloids from Murraya koenigii as Potential SARS-CoV-2 Main Protease Inhibitors.
    Wadanambi PM, Jayathilaka N, Seneviratne KN.
    Appl Biochem Biotechnol; 2023 Jan; 195(1):573-596. PubMed ID: 36107386
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous quantitation of nine carbazole alkaloids from Murraya koenigii (L.) Spreng by 1H qNMR spectroscopy.
    Chatterjee D, Narzish F, Borade P, Singh IP.
    Nat Prod Res; 2024 Sep; 38(18):3173-3181. PubMed ID: 37322993
    [Abstract] [Full Text] [Related]

  • 3. Investigating the antiviral therapeutic potentialities of marine polycyclic lamellarin pyrrole alkaloids as promising inhibitors for SARS-CoV-2 and Zika main proteases (Mpro).
    Pereira F, Bedda L, Tammam MA, Alabdullah AK, Arafa R, El-Demerdash A.
    J Biomol Struct Dyn; 2024 May; 42(8):3983-4001. PubMed ID: 37232419
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxicity and Proteasome Inhibition by Alkaloid Extract from Murraya koenigii Leaves in Breast Cancer Cells-Molecular Docking Studies.
    Ismail A, Noolu B, Gogulothu R, Perugu S, Rajanna A, Babu SK.
    J Med Food; 2016 Dec; 19(12):1155-1165. PubMed ID: 27982755
    [Abstract] [Full Text] [Related]

  • 5. Investigating the structure-activity relationship of marine polycyclic batzelladine alkaloids as promising inhibitors for SARS-CoV-2 main protease (Mpro).
    Elgohary AM, Elfiky AA, Pereira F, Abd El-Aziz TM, Sobeh M, Arafa RK, El-Demerdash A.
    Comput Biol Med; 2022 Aug; 147():105738. PubMed ID: 35777088
    [Abstract] [Full Text] [Related]

  • 6. Comparison of antioxidative properties of carbazole alkaloids from Murraya koenigii leaves.
    Tachibana Y, Kikuzaki H, Lajis NH, Nakatani N.
    J Agric Food Chem; 2003 Oct 22; 51(22):6461-7. PubMed ID: 14558763
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
    El-Demerdash A, Metwaly AM, Hassan A, Abd El-Aziz TM, Elkaeed EB, Eissa IH, Arafa RK, Stockand JD.
    Biomolecules; 2021 Mar 19; 11(3):. PubMed ID: 33808721
    [Abstract] [Full Text] [Related]

  • 8. Quantitative Analysis of Bioactive Carbazole Alkaloids in Murraya koenigii (L.) from Six Different Climatic Zones of India Using UPLC/MS/MS and Their Principal Component Analysis.
    Nandan S, Singh SK, Singh P, Bajpai V, Mishra AK, Joshi T, Mahar R, Shukla SK, Mishra DK, Kanojiya S.
    Chem Biodivers; 2021 Dec 19; 18(12):e2100557. PubMed ID: 34643999
    [Abstract] [Full Text] [Related]

  • 9. Marine Brominated Tyrosine Alkaloids as Promising Inhibitors of SARS-CoV-2.
    El-Demerdash A, Hassan A, Abd El-Aziz TM, Stockand JD, Arafa RK.
    Molecules; 2021 Oct 13; 26(20):. PubMed ID: 34684755
    [Abstract] [Full Text] [Related]

  • 10. Four new carbazole alkaloids from Murraya koenigii that display anti-inflammatory and anti-microbial activities.
    Nalli Y, Khajuria V, Gupta S, Arora P, Riyaz-Ul-Hassan S, Ahmed Z, Ali A.
    Org Biomol Chem; 2016 Mar 28; 14(12):3322-32. PubMed ID: 26947457
    [Abstract] [Full Text] [Related]

  • 11. A new carbazole alkaloid from the leaves of Malayan Murraya koenigii.
    Sim KM, Teh HM.
    J Asian Nat Prod Res; 2011 Oct 28; 13(10):972-5. PubMed ID: 21972815
    [Abstract] [Full Text] [Related]

  • 12. In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2.
    Shah M, Yamin R, Ahmad I, Wu G, Jahangir Z, Shamim A, Nawaz H, Nishan U, Ullah R, Ali EA, Sheheryar, Chen K.
    PLoS One; 2024 Oct 28; 19(1):e0294769. PubMed ID: 38175855
    [Abstract] [Full Text] [Related]

  • 13. Indole alkaloids as potential candidates against COVID-19: an in silico study.
    Mohseni M, Bahrami H, Farajmand B, Hosseini FS, Amanlou M, Salehabadi H.
    J Mol Model; 2022 May 11; 28(6):144. PubMed ID: 35546368
    [Abstract] [Full Text] [Related]

  • 14. Bioactive carbazole alkaloids from Murraya koenigii (L.) Spreng.
    Ma Q, Tian J, Yang J, Wang A, Ji T, Wang Y, Su Y.
    Fitoterapia; 2013 Jun 11; 87():1-6. PubMed ID: 23500386
    [Abstract] [Full Text] [Related]

  • 15. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.
    Batool F, Mughal EU, Zia K, Sadiq A, Naeem N, Javid A, Ul-Haq Z, Saeed M.
    J Biomol Struct Dyn; 2022 May 11; 40(8):3777-3788. PubMed ID: 33251983
    [Abstract] [Full Text] [Related]

  • 16. Investigation of bio-active Amaryllidaceae alkaloidal small molecules as putative SARS-CoV-2 main protease and host TMPRSS2 inhibitors: interpretation by in-silico simulation study.
    Bhowmick S, Mistri TK, Khan MR, Patil PC, Busquets R, Ashif Ikbal AM, Choudhury A, Roy DK, Palit P, Saha A.
    J Biomol Struct Dyn; 2024 Sep 11; 42(14):7107-7127. PubMed ID: 37482789
    [Abstract] [Full Text] [Related]

  • 17. Optimization Rules for SARS-CoV-2 Mpro Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site.
    Stoddard SV, Stoddard SD, Oelkers BK, Fitts K, Whalum K, Whalum K, Hemphill AD, Manikonda J, Martinez LM, Riley EG, Roof CM, Sarwar N, Thomas DM, Ulmer E, Wallace FE, Pandey P, Roy S.
    Viruses; 2020 Aug 26; 12(9):. PubMed ID: 32859008
    [Abstract] [Full Text] [Related]

  • 18. Anti-colon cancer activity of Murraya koenigii leaves is due to constituent murrayazoline and O-methylmurrayamine A induced mTOR/AKT downregulation and mitochondrial apoptosis.
    Arun A, Patel OPS, Saini D, Yadav PP, Konwar R.
    Biomed Pharmacother; 2017 Sep 26; 93():510-521. PubMed ID: 28675857
    [Abstract] [Full Text] [Related]

  • 19. Three new carbazole alkaloids and biological activities of Murraya koenigii.
    Naz S, Saied S, Ahmed A, Shahid SM.
    J Asian Nat Prod Res; 2015 Sep 26; 17(1):7-13. PubMed ID: 25291407
    [Abstract] [Full Text] [Related]

  • 20. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y, Singh H, Patel CN.
    J Infect Public Health; 2020 Sep 26; 13(9):1210-1223. PubMed ID: 32561274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.